• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体α PvuII基因多态性与前列腺癌风险之间的关联。

Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.

作者信息

Li Liang, Zhang Xuening, Xia Qinglai, Ma Hui, Chen Li, Hou Wenjing

机构信息

Department of Radiology, Second Affiliated Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, China.

出版信息

Tumour Biol. 2014 May;35(5):4629-35. doi: 10.1007/s13277-014-1606-9. Epub 2014 Jan 12.

DOI:10.1007/s13277-014-1606-9
PMID:24414486
Abstract

Accumulating evidence has suggested that estrogen receptor alpha (ER-α) PvuII polymorphism might be involved in the development of prostate cancer (PCa). However, the results have been inconsistent. We therefore performed a meta-analysis to clarify the associations between ER-α PvuII polymorphism and PCa. A comprehensive search was conducted to identify all case-control studies of ER-α PvuII polymorphism and PCa risk. We used odds ratios (ORs) to assess the strength of the association and 95% confidence intervals (CIs) to give a sense of the precision of the estimate. A total of 14 studies were found to be eligible for meta-analyses of PvuII variant. Results from this study showed that ER-α PvuII polymorphism were significantly associated with PCa risk under all genetic models in overall population (homogeneous codominant model, OR = 1.57, 95% CI = 1.11-2.21, P = 0.010; heterogeneous codominant model, OR = 1.37, 95% CI = 1.06-1.77, P = 0.02; recessive model, OR = 1.27, 95% CI = 1.02-1.57, P = 0.03; dominant model, OR = 1.40, 95% CI = 1.09-1.79, P = 0.009; and allelic model, OR = 1.25, 95% CI = 1.06-1.48, P = 0.010). Further sensitivity analysis confirmed the significant association. In subgroup analyses stratified by PCa type, there was a significant association between PvuII polymorphism and sporadic PCa risk under both Caucasians and Asians. The meta-analysis indicated elected PvuII polymorphism of ER-α was a risk factor for PCa development.

摘要

越来越多的证据表明,雌激素受体α(ER-α)PvuII基因多态性可能与前列腺癌(PCa)的发生有关。然而,研究结果并不一致。因此,我们进行了一项荟萃分析,以阐明ER-α PvuII基因多态性与PCa之间的关联。我们进行了全面检索,以确定所有关于ER-α PvuII基因多态性与PCa风险的病例对照研究。我们使用比值比(OR)来评估关联强度,并使用95%置信区间(CI)来表示估计的精确度。共有14项研究符合PvuII变异体荟萃分析的条件。本研究结果表明,在总体人群的所有遗传模型下,ER-α PvuII基因多态性与PCa风险显著相关(共显性模型,OR = 1.57,95% CI = 1.11 - 2.21,P = 0.010;异质性共显性模型,OR = 1.37,95% CI = 1.06 - 1.77,P = 0.02;隐性模型,OR = 1.27,95% CI = 1.02 - 1.57,P = 0.03;显性模型,OR = 1.40,95% CI = 1.09 - 1.79,P = 0.009;等位基因模型,OR = 1.25,95% CI = 1.06 - 1.48,P = 0.010)。进一步的敏感性分析证实了这种显著关联。在按PCa类型分层的亚组分析中,在白种人和亚洲人中,PvuII基因多态性与散发性PCa风险之间均存在显著关联。荟萃分析表明,ER-α的PvuII基因多态性是PCa发生的一个危险因素。

相似文献

1
Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.雌激素受体α PvuII基因多态性与前列腺癌风险之间的关联。
Tumour Biol. 2014 May;35(5):4629-35. doi: 10.1007/s13277-014-1606-9. Epub 2014 Jan 12.
2
Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.雌激素受体α基因多态性与前列腺癌风险:一项纳入18项研究的荟萃分析。
Tumour Biol. 2014 Jun;35(6):5921-30. doi: 10.1007/s13277-014-1785-4. Epub 2014 Mar 1.
3
Estrogen receptor-alpha gene PvuII (T/C) and XbaI (A/G) polymorphisms and endometriosis risk: a meta-analysis.雌激素受体-α基因 PvuII(T/C)和 XbaI(A/G)多态性与子宫内膜异位症风险的关系:一项荟萃分析。
Gene. 2012 Oct 15;508(1):41-8. doi: 10.1016/j.gene.2012.07.049. Epub 2012 Aug 4.
4
Protective effect of oestrogen receptor α-PvuII transition against idiopathic male infertility: a case-control study and meta-analysis.雌激素受体 α-PvuII 转换对特发性男性不育的保护作用:病例对照研究和荟萃分析。
Reprod Biomed Online. 2019 Apr;38(4):588-598. doi: 10.1016/j.rbmo.2019.01.008. Epub 2019 Jan 23.
5
Associations of Estrogen Receptor Alpha Gene Polymorphisms with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Systematic Review and Meta-Analysis.雌激素受体 α 基因多态性与 2 型糖尿病及代谢综合征的相关性:系统评价和荟萃分析。
Horm Metab Res. 2018 Jun;50(6):469-477. doi: 10.1055/a-0620-8553. Epub 2018 Jun 8.
6
Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis.COX-2 rs2745557 多态性与前列腺癌风险的关联:系统评价和荟萃分析。
BMC Immunol. 2012 Mar 21;13:14. doi: 10.1186/1471-2172-13-14.
7
Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.雌激素受体 α(rs2234693 和 rs9340799)和 β(rs4986938 和 rs1256049)基因多态性与前列腺癌的关系:伊朗男性风险和组织病理学肿瘤特征的关联证据。
Mol Carcinog. 2012 Oct;51 Suppl 1:E104-17. doi: 10.1002/mc.21870. Epub 2012 Jan 6.
8
Association between estrogen receptora gene (ESR1) PvuII (T/C) and XbaI (A/G) polymorphisms and premature ovarian failure risk: evidence from a meta-analysis.雌激素受体α基因(ESR1)PvuII(T/C)和XbaI(A/G)多态性与卵巢早衰风险之间的关联:一项荟萃分析的证据
J Assist Reprod Genet. 2015 Feb;32(2):297-304. doi: 10.1007/s10815-014-0393-y. Epub 2014 Nov 27.
9
The estrogen receptor α gene (XbaI, PvuII) polymorphisms and susceptibility to idiopathic scoliosis: a meta-analysis.雌激素受体α基因(XbaI、PvuII)多态性与特发性脊柱侧凸易感性的Meta分析
J Orthop Sci. 2014 Sep;19(5):713-21. doi: 10.1007/s00776-014-0597-0. Epub 2014 Jun 25.
10
Estrogen receptor alpha gene PvuII polymorphism and risk of fracture in postmenopausal women: a meta-analysis.雌激素受体α基因PvuII多态性与绝经后女性骨折风险:一项荟萃分析。
Genet Mol Res. 2015 Feb 13;14(1):1293-300. doi: 10.4238/2015.February.13.8.

引用本文的文献

1
Association between ESR1 rs2234693 single nucleotide polymorphism and uterine fibroids in Taiwanese premenopausal and postmenopausal women.台湾绝经前和绝经后妇女中 ESR1 rs2234693 单核苷酸多态性与子宫肌瘤的关联。
J Health Popul Nutr. 2023 Mar 8;42(1):16. doi: 10.1186/s41043-023-00357-7.
2
PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies.PvuII(rs2234693 T>C)多态性与癌症易感性:来自80项研究的证据。
J Cancer. 2018 Jul 30;9(16):2963-2972. doi: 10.7150/jca.25638. eCollection 2018.

本文引用的文献

1
Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.基于NUCB2蛋白评估的前列腺癌预后预测:前列腺癌中的NUCB2
J Exp Clin Cancer Res. 2013 Oct 16;32(1):77. doi: 10.1186/1756-9966-32-77.
2
High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer.核结合蛋白2信使核糖核酸的高表达:前列腺癌患者总生存的独立预后因素
Tumour Biol. 2014 Mar;35(3):2025-8. doi: 10.1007/s13277-013-1268-z. Epub 2013 Oct 4.
3
Clinical significance of NUCB2 mRNA expression in prostate cancer.
前列腺癌中 NUCB2 mRNA 表达的临床意义。
J Exp Clin Cancer Res. 2013 Aug 16;32(1):56. doi: 10.1186/1756-9966-32-56.
4
Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.亚甲基四氢叶酸脱氢酶 1 多态性与癌症的关联:一项荟萃分析。
PLoS One. 2013 Jul 19;8(7):e69366. doi: 10.1371/journal.pone.0069366. Print 2013.
5
CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.CYP1B1 多态性与前列腺癌易感性的关系:一项荟萃分析。
PLoS One. 2013 Jul 4;8(7):e68634. doi: 10.1371/journal.pone.0068634. Print 2013.
6
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.在接受紫杉醇/铂类一线化疗的上皮性卵巢癌患者中,tau 蛋白作为一种潜在的预测标志物。
J Exp Clin Cancer Res. 2013 Apr 30;32(1):25. doi: 10.1186/1756-9966-32-25.
7
Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis.SMAD7 rs12953717 多态性与癌症的关联:一项荟萃分析。
PLoS One. 2013;8(3):e58170. doi: 10.1371/journal.pone.0058170. Epub 2013 Mar 5.
8
A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.直接测序法、焦磷酸测序法、高分辨率熔解曲线分析、TheraScreen DxS 与 K-ras StripAssay 检测非小细胞肺癌 KRAS 突变的比较。
J Exp Clin Cancer Res. 2012 Sep 20;31(1):79. doi: 10.1186/1756-9966-31-79.
9
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.CD133 表达增加和抗肌萎缩蛋白表达减少是结直肠癌患者预后不良的强烈预测指标。
J Exp Clin Cancer Res. 2012 Sep 11;31(1):71. doi: 10.1186/1756-9966-31-71.
10
An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions.一种由人附睾蛋白4(HE4)、癌抗原125(CA125)、超声评分和绝经状态组成的卵巢癌恶性风险指数:用于卵巢癌与良性病变的鉴别诊断
Tumour Biol. 2012 Oct;33(5):1811-7. doi: 10.1007/s13277-012-0440-1. Epub 2012 Jun 14.